A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)
Clinical trial NCT03126799 · UNKNOWN
Trial details
- NCT number
- NCT03126799
- Sponsor
- National Cancer Center, Korea
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2021-12-31
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.